跳至主要内容
临床试验/NCT05289622
NCT05289622Unknown不适用

Single-arm Prospectus Study to Evaluate the Safety and Security of the Expandable Valve Stent, Approach Technique and Its Implantation in the Pulmonary Position

Dr. Miguel Angel Maluf2 个研究点 分布在 1 个国家目标入组 5 人开始时间: 2022年10月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
5
试验地点
2
主要终点
Pulmonary Regurgitation After Polyurethane Expandable Valve Stent Implant Surgery

研究概览

简要总结

Prospective Study, Single Arm to evaluate the safety and efficacy of polyurethane expandable valve implantation in the pulmonary position, in 5 patients over 18 years of age, with pulmonary valve dysfunction and moderate to severe impairment of Right Ventricular function. During throughout the study, safety parameters related to valve operation will be evaluated (patient's Functional Class), in addition to the occurrence of Serious Adverse Events. After the procedure, the patient must be hospitalized in the Intensive Care Unit until the complete hemodynamic stabilization and normalization of lung function and in good general condition (2 to 3 days of stay) and then transferred to the ward (2 to 3 days and stay) before hospital discharge. A formal Statistical Analysis Plan (SAP) will be developed and finalized before closing the database. Full details of data presentations and analysis will be provided in SAP.

Additional statistical analyses, other than those described in this section, may be performed if deemed appropriate and included in SAP. Any deviations from the final analysis plan or what is presented in the protocol will be discussed in the final study report. No formal inferential statistics will be applied to the data collected in the study.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Device Feasibility
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients aged 18 years or older;
  • Pulmonary valve dysfunction and moderate to severe impairment of Right Ventricle function;
  • Functional Class II to IV New York Heart Association (NYHA) classification of heart failure.

排除标准

  • Impairment of cardiovascular function;
  • Neurological impairment;
  • Syndromes without prognosis or survival of less than 1 year;
  • Carriers of infection undergoing medical treatment;
  • Patients undergoing artificial life support;
  • Known hypersensitivity to aspirin or heparin;
  • Positive urine or serum test for pregnancy in female patients of reproductive age.

结局指标

主要结局

Pulmonary Regurgitation After Polyurethane Expandable Valve Stent Implant Surgery

时间窗: 6 months

if there are changes in pulmonary regurgitation (PR): discreet or less (≤2+) on transthoracic echocardiogram (TTE).

次要结局

未报告次要终点

研究者

发起方
Dr. Miguel Angel Maluf
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Dr. Miguel Angel Maluf

Principal Investigator

Hospital Alemão Oswaldo Cruz

研究点 (2)

Loading locations...

相似试验